Market Overview:
The global Alunbrig market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented by type (30mg, 50mg, 180mg), by application (hospital, pharmacy) and region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). The growth in the Alunbrig market can be attributed to factors such as the increasing incidence of cancer globally and rising demand for targeted therapies. Additionally, the increasing focus on personalized medicine is also contributing to the growth of this market. However, patent expiries for blockbuster drugs are likely to restrain the growth of this market in the coming years.
Product Definition:
Alunbrig is a chemotherapy drug used to treat non-small cell lung cancer. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs).
30mg:
30mg is a high strength pain relief medication used for the treatment of severe chronic pain. It’s an off-label drug, which means that it has been approved by the FDA to treat some specific conditions but not for its exact indication. The 30 mg tablets are white and diamond shaped and are available OTC in all pharmacies, supermarkets & e-commerce platforms worldwide.
50mg:
50mg is used for the treatment of hyperthyroidism and goiter. It is also used in cases where a patient has difficulty swallowing due to enlargement of the thyroid gland.
Application Insights:
The application segment is segregated into hospital and pharmacy. In 2017, the hospital segment dominated the global market with a revenue share of over 90%. The dominance is attributed to factors such as increasing prevalence of chronic diseases, rising geriatric population across the globe and growing healthcare expenditure.
The aluminum hydroxide-based products are used in hospitals for treating patients suffering from acute kidney failure or AKF. These are also used in cases where there is an accumulation of fluid in the lungs due to respiratory problems or congestion caused due to bacterial infection. It helps remove toxins from body tissues and organs thereby improving overall health conditions in patients suffering from acute kidney failure orAKF at a faster rate than conventional dialysis techniques do.
Regional Analysis:
North America dominated the global market in 2017. The growth is attributed to the presence of a large number of key players, high adoption rate for new technologies, and favorable reimbursement policies pertaining to drug costs. Moreover, increasing R&D activities by major companies is expected to fuel regional market growth over the forecast period.
Asia Pacific region is anticipated to witness lucrative CAGR during the forecast period owing to factors such as growing healthcare spending and rising prevalence of chronic diseases coupled with improving economic conditions in emerging countries such as China and India are some factors that can be attributed for this rapid growth. Furthermore, increasing investments by governments in developing healthcare infrastructure are also contributing towards industry expansion over this region’s demand side.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the Alunbrig market. According to a study by American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in United States in 2017. This number is expected to rise in the coming years due to increase in aging population and lifestyle-related diseases such as obesity and smoking. This will create demand for novel targeted therapies such as Alunbrig and drive the growth of the market.
- Rising awareness about personalized medicine: There is an increasing trend towards personalized medicine across the globe due to its benefits over traditional chemotherapy regimens. Personalized medicine takes into account individual variability in genes, environment, and lifestyle factors to provide treatment that is tailored for each patient’s unique needs. This has led to rising demand for targeted therapies such as Alunbrig which offer better efficacy and fewer side effects than traditional chemotherapy drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Alunbrig Market Research Report
By Type
30mg, 50mg, 180mg
By Application
Hospital, Pharmacy
By Companies
ARIAD Pharmaceuticals, ARIAD Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Alunbrig Market Report Segments:
The global Alunbrig market is segmented on the basis of:
Types
30mg, 50mg, 180mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ARIAD Pharmaceuticals
- ARIAD Pharmaceuticals
Highlights of The Alunbrig Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 30mg
- 50mg
- 180mg
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alunbrig Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Some of the major companies in the alunbrig market are ARIAD Pharmaceuticals, ARIAD Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Alunbrig Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Alunbrig Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Alunbrig Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Alunbrig Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Alunbrig Market Size & Forecast, 2018-2028
4.5.1 Alunbrig Market Size and Y-o-Y Growth
4.5.2 Alunbrig Market Absolute $ Opportunity
Chapter 5 Global Alunbrig Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Alunbrig Market Size Forecast by Type
5.2.1 30mg
5.2.2 50mg
5.2.3 180mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Alunbrig Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Alunbrig Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Alunbrig Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Alunbrig Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Alunbrig Analysis and Forecast
9.1 Introduction
9.2 North America Alunbrig Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Alunbrig Market Size Forecast by Type
9.6.1 30mg
9.6.2 50mg
9.6.3 180mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Alunbrig Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Alunbrig Analysis and Forecast
10.1 Introduction
10.2 Europe Alunbrig Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Alunbrig Market Size Forecast by Type
10.6.1 30mg
10.6.2 50mg
10.6.3 180mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Alunbrig Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Alunbrig Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Alunbrig Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Alunbrig Market Size Forecast by Type
11.6.1 30mg
11.6.2 50mg
11.6.3 180mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Alunbrig Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Alunbrig Analysis and Forecast
12.1 Introduction
12.2 Latin America Alunbrig Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Alunbrig Market Size Forecast by Type
12.6.1 30mg
12.6.2 50mg
12.6.3 180mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Alunbrig Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Alunbrig Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Alunbrig Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Alunbrig Market Size Forecast by Type
13.6.1 30mg
13.6.2 50mg
13.6.3 180mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Alunbrig Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Alunbrig Market: Competitive Dashboard
14.2 Global Alunbrig Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ARIAD Pharmaceuticals
14.3.2 ARIAD Pharmaceuticals
